AGGRENOX از شرکت BOEHRINGER INGELHEIM

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

AGGRENOX از شرکت BOEHRINGER INGELHEIM

New Drug Application (NDA): 020884

Company: BOEHRINGER INGELHEIM

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
AGGRENOX ASPIRIN; DIPYRIDAMOLE 25MG;200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

AB

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
11/22/1999 ORIG-1 Approval

Type 4 – New Combination

PRIORITY

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20884_AGGRENOX_prntlbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20884_AGGRENOX_APPROV.PDF
https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20884_Aggrenox.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
05/13/2021 SUPPL-40 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020884s040lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/020884Orig1s040ltr.pdf

12/11/2019 SUPPL-39 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020884s039lbledt.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/020884Orig1s039ltr.pdf

11/09/2018 SUPPL-37 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020884s037lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/020884Orig1s037ltr.pdf

11/09/2015 SUPPL-35 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020884s035lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020884Orig1s035ltr.pdf

05/30/2014 SUPPL-33 Manufacturing (CMC)

Label is not available on this site.

05/29/2013 SUPPL-32 Manufacturing (CMC)

Label is not available on this site.

09/07/2012 SUPPL-30 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020884s030lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020884Orig1s030ltr.pdf

10/01/2009 SUPPL-18 Efficacy-Labeling Change With Clinical Data

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020884s018lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020884s018ltr.pdf

11/28/2006 SUPPL-14 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020884s014lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020884s014ltr.pdf

03/26/2007 SUPPL-12 Efficacy-Labeling Change With Clinical Data

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020884s012lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020884s012ltr.pdf

01/28/2004 SUPPL-7 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20884slr007ltr.pdf

06/20/2002 SUPPL-6 Manufacturing (CMC)-Control

Label is not available on this site.

02/08/2002 SUPPL-5 Manufacturing (CMC)

Label is not available on this site.

09/21/2001 SUPPL-4 Manufacturing (CMC)-Control

Label is not available on this site.

04/23/2001 SUPPL-3 Manufacturing (CMC)-Packaging

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/20884S3ltr.pdf

10/17/2000 SUPPL-2 Manufacturing (CMC)

Label is not available on this site.

08/10/2001 SUPPL-1 Labeling

Label (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20884s1lbl.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
05/13/2021 SUPPL-40

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020884s040lbl.pdf
12/11/2019 SUPPL-39

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020884s039lbledt.pdf
11/09/2018 SUPPL-37

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020884s037lbl.pdf
11/09/2015 SUPPL-35

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020884s035lbl.pdf
09/07/2012 SUPPL-30

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020884s030lbl.pdf
10/01/2009 SUPPL-18

Efficacy-Labeling Change With Clinical Data

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020884s018lbl.pdf
03/26/2007 SUPPL-12

Efficacy-Labeling Change With Clinical Data

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020884s012lbl.pdf
11/28/2006 SUPPL-14

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020884s014lbl.pdf
08/10/2001 SUPPL-1

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20884s1lbl.pdf
11/22/1999 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20884_AGGRENOX_prntlbl.pdf

AGGRENOX

CAPSULE, EXTENDED RELEASE;ORAL; 25MG;200MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AGGRENOX ASPIRIN; DIPYRIDAMOLE 25MG;200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 020884 BOEHRINGER INGELHEIM
ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE 25MG;200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 206392 AMNEAL PHARMS
ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE 25MG;200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 078804 BARR
ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE 25MG;200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 209048 DR REDDYS
ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE 25MG;200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 210318 GLENMARK PHARMS SA
ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE 25MG;200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 207944 PAR PHARM INC
ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE 25MG;200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 206739 SANDOZ INC
ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE 25MG;200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 208572 SUN PHARM
ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE 25MG;200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 206753 ZYDUS PHARMS
بخوانید  CEFAZOLIN SODIUM از شرکت HOSPIRA INC
به بالای صفحه بردن